Bay Street News, 2024

As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in […]

As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific […]

SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth […]

TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to provide a […]

MIAMI, FL and KANSAS CITY, KS, Sept. 20, 2024 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (Nasdaq: CLOE) (“CLOE” or […]

TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has […]

BROOKFIELD, NEWS, Sept. 20, 2024 (GLOBE NEWSWIRE) — Brookfield Corporation (NYSE: BN, TSX: BN) today announced that after having taken […]

ISTANBUL, Sept. 20, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce […]

NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (NASDAQ: CJET) (the “Company”), a high-tech enterprise engaged […]

BRISBANE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted […]